These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 14688079)

  • 21. From genome screening to creation of vaccine against Trypanosoma cruzi by use of immunoinformatics.
    Teh-Poot C; Tzec-Arjona E; Martínez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Dumonteil E
    J Infect Dis; 2015 Jan; 211(2):258-66. PubMed ID: 25070943
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vaccine-linked chemotherapy with a low dose of benznidazole plus a bivalent recombinant protein vaccine prevents the development of cardiac fibrosis caused by Trypanosoma cruzi in chronically-infected BALB/c mice.
    Dzul-Huchim VM; Ramirez-Sierra MJ; Martinez-Vega PP; Rosado-Vallado ME; Arana-Argaez VE; Ortega-Lopez J; Gusovsky F; Dumonteil E; Cruz-Chan JV; Hotez P; Bottazzi ME; Villanueva-Lizama LE
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010258. PubMed ID: 36095001
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parasite-induced chronic inflammation is not exacerbated by immunotherapy before or during Trypanosoma cruzi Infection.
    Duthie MS; Kahn M; Zakayan A; White M; Kahn SJ
    Clin Vaccine Immunol; 2007 Aug; 14(8):1005-12. PubMed ID: 17538117
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
    Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
    Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trypanosoma cruzi Tc24 Antigen Expressed and Orally Delivered by Schizochytrium sp. Microalga is Immunogenic in Mice.
    Ramos-Vega A; Monreal-Escalante E; Rosales-Mendoza S; Bañuelos-Hernández B; Dumonteil E; Angulo C
    Mol Biotechnol; 2024 Jun; 66(6):1376-1388. PubMed ID: 37344711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Coadministration of an interleukin-12 gene and a Trypanosoma cruzi gene improves vaccine efficacy.
    Katae M; Miyahira Y; Takeda K; Matsuda H; Yagita H; Okumura K; Takeuchi T; Kamiyama T; Ohwada A; Fukuchi Y; Aoki T
    Infect Immun; 2002 Sep; 70(9):4833-40. PubMed ID: 12183527
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.
    Aparicio-Burgos JE; Ochoa-García L; Zepeda-Escobar JA; Gupta S; Dhiman M; Martínez JS; de Oca-Jiménez RM; Val Arreola M; Barbabosa-Pliego A; Vázquez-Chagoyán JC; Garg NJ
    PLoS Negl Trop Dis; 2011; 5(5):e1050. PubMed ID: 21625470
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA Vaccine Treatment in Dogs Experimentally Infected with
    Arce-Fonseca M; Carbajal-Hernández AC; Lozano-Camacho M; Carrillo-Sánchez SDC; Roldán FJ; Aranda-Fraustro A; Rosales-Encina JL; Rodríguez-Morales O
    J Immunol Res; 2020; 2020():9794575. PubMed ID: 32455143
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunization with a plasmid DNA containing the gene of trans-sialidase reduces Trypanosoma cruzi infection in mice.
    Costa F; Franchin G; Pereira-Chioccola VL; Ribeirão M; Schenkman S; Rodrigues MM
    Vaccine; 1998 May; 16(8):768-74. PubMed ID: 9627933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a purified Trypanosoma cruzi antigen and CpG oligodeoxynucleotides for immunoprotection against a lethal challenge with trypomastigotes.
    Frank FM; Petray PB; Cazorla SI; Muñoz MC; Corral RS; Malchiodi EL
    Vaccine; 2003 Dec; 22(1):77-86. PubMed ID: 14604574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vaccination with parasite-specific TcTASV proteins combined with recombinant baculovirus as a delivery platform protects against acute and chronic
    Masip YE; Caeiro LD; Cosenza M; Postan M; Molina G; Taboga O; Molinari MP; Tekiel V
    Front Cell Infect Microbiol; 2024; 14():1297321. PubMed ID: 38481660
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
    Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
    Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunological and pathological responses in BALB/c mice induced by genetic administration of Tc 13 Tul antigen of Trypanosoma cruzi.
    García GA; Arnaiz MR; Laucella SA; Esteva MI; Ainciart N; Riarte A; Garavaglia PA; Fichera LE; Ruiz AM
    Parasitology; 2006 Jun; 132(Pt 6):855-66. PubMed ID: 16478565
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cysteine mutagenesis improves the production without abrogating antigenicity of a recombinant protein vaccine candidate for human chagas disease.
    Seid CA; Jones KM; Pollet J; Keegan B; Hudspeth E; Hammond M; Wei J; McAtee CP; Versteeg L; Gutierrez A; Liu Z; Zhan B; Respress JL; Strych U; Bottazzi ME; Hotez PJ
    Hum Vaccin Immunother; 2017 Mar; 13(3):621-633. PubMed ID: 27737611
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Experimental Chagas disease in Balb/c mice previously vaccinated with T. rangeli. II. The innate immune response shows immunological memory: reality or fiction?
    Basso B; Marini V
    Immunobiology; 2015 Mar; 220(3):428-36. PubMed ID: 25454810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic Adjuvantation of a Cell-Based Therapeutic Vaccine for Amelioration of Chagasic Cardiomyopathy.
    Konduri V; Halpert MM; Liang D; Levitt JM; Cruz-Chan JV; Zhan B; Bottazzi ME; Hotez PJ; Jones KM; Decker WK
    Infect Immun; 2017 Sep; 85(9):. PubMed ID: 28674032
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune responses to gp82 provide protection against mucosal Trypanosoma cruzi infection.
    Eickhoff CS; Giddings OK; Yoshida N; Hoft DF
    Mem Inst Oswaldo Cruz; 2010 Aug; 105(5):687-91. PubMed ID: 20835618
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.
    Bhatia V; Sinha M; Luxon B; Garg N
    Infect Immun; 2004 Nov; 72(11):6245-54. PubMed ID: 15501750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. During Trypanosoma cruzi infection CD1d-restricted NK T cells limit parasitemia and augment the antibody response to a glycophosphoinositol-modified surface protein.
    Duthie MS; Wleklinski-Lee M; Smith S; Nakayama T; Taniguchi M; Kahn SJ
    Infect Immun; 2002 Jan; 70(1):36-48. PubMed ID: 11748161
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    Gupta S; Salgado-Jiménez B; Lokugamage N; Vázquez-Chagoyán JC; Garg NJ
    Front Immunol; 2019; 10():1456. PubMed ID: 31293599
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.